Clinical ThyroidologyVol. 33, No. 6

Thyroid Eye Disease

Published Online:8 Jun 2021

Carlos Morillas, Luis D’Marco, María Jesús Puchades, Eva Solá-Izquierdo, Carmen Gorriz-Zambrano, Valmore Bermúdez and José Luis Gorriz

Int. J. Environ. Res. Public Health 2021, 18(10), 5388; https://doi.org/10.3390/ijerph18105388 (registering DOI)

Published: 18 May 2021

Published Online:12 Apr 2021

https://doi.org/10.1089/thy.2020.0356

European Journal of Nuclear Medicine and Molecular Imaging (2021)

Published: 10 April 2021

Teprotumumab for patients with active thyroid eye disease: a pooled data analysis, subgroup analyses, and off-treatment follow-up results from two randomised, double-masked, placebo-controlled, multicentre trials

Published:April 15, 2021

DOI: https://doi.org/10.1016/S2213-8587(21)00056-5

Recent developments in the management of Cushing's syndrome

Pablo Abellán Galiana

EDITORIAL

DOI: 10.1016/j.endinu.2021.01.002

Pituitary (2021)

Abstract

Purpose

We report a case of a pregnant woman with Cushing’s disease (CD) and performed a systematic review of literature on diagnosis, treatment, maternal and fetal outcomes of CD in pregnancy.

https://doi.org/10.1016/j.atherosclerosis.2021.03.003